Shane Neibart, Resident Physician at Harvard Radiation Oncology Program, shared on X:
“More on RT Toxicity:
HYPNO trial published and I will leave it to others for the deep dive.
I wonder if we should interpret the acute toxicity data with caution…”
Title: Hypofractionated Versus Normofractionated Accelerated Radiation Therapy With or Without Cisplatin for Locally Advanced Head and Neck Squamous Cell Carcinoma (HYPNO): A Randomized, Open-Label, Phase 3, Noninferiority Trial
Authors: Søren Bentzen, Tejpal Gupta, Alexandre Jacinto, Eduardo Rosenblatt, Suman Bhasker, Misleidy Napoles, Sergio Binia, Yaowalak Chansilpa, Sergio Aguiar, Murugaiyan Nagarajan, Sarbani Laskar, Pedro De Marchi, Olga Goloubeva, Kirsten Hopkins, Eduardo Zubizarreta, Jai Agarwal, May Abdel-Wahab
Read the Full Article.
Other articles featuring Shane Neibart on OncoDaily.